|
FDA Patient Safety News (PSN) is a monthly video news show for healthcare professionals. It covers significant safety alerts, recalls, new product approvals, and offers important tips on protecting patients. Read the complete stories and watch or download the video program at www.fda.gov/psn. You may have already received notification of some of these safety issues through the MedWatch E-list. However, many of these PSN stories contain video footage and demonstrations that may be especially useful to clinicians and educators in healthcare facilities and academic institutions.
Stories in the June 2010 edition include:
Reformulation makes it more difficult to misuse or abuse the drug…
First Absorbable Sealant Patch for Cardiovascular Surgery
TachoSil provides surgeons with an additional tool to help control bleeding…
Reduced Effect from Plavix in Some Patients
Tests are available to identify "poor metabolizers" of the drug based on genetic makeup…
Muscle Injury from High Doses of Zocor
Ongoing safety review indicates increased risk of muscle injury with 80 mg. dose of simvastatin…
Companies to Stop Marketing Unapproved Nitroglycerin Tablets
Hospitals and pharmacies that buy unapproved nitroglycerin tablets from Glenmark Generics and Konec Inc. will need to switch to approved ones…
Boxed Warning for Exjade
Warning highlights the need for close monitoring of a patient's renal and hepatic function…
Hemolysis Risk with WinRho SDF
Closely monitor patients for signs and symptoms of hemolysis…
Avoiding Problems with Temporary Cardiac Pacing
An FDA article from Nursing2010 on ways to avoid misconnections, disconnections, and lead fractures…
Caution about Sexual Enhancement Supplements
“All natural" supplements may contain ingredients that could pose a serious health risk…
Patients using Aerobid, Combivent or Maxair should talk to their doctors about switching to another product…
You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · 10903 New Hampshire Ave MD 20993 · 800-439-1420
